Back pain after photodynamic therapy with verteporfin.

Maria Vadala', Alfredo Pece, Renato Manzi, Giliola Calori

Risultato della ricerca: Article

5 Citazioni (Scopus)

Abstract

PURPOSE:To report the incidence of back pain after photodynamic therapy, which suggests methods for prevention that are related to its pathogenesis.DESIGN:Retrospective case series.METHODS:We retrospectively observed 548 patients who had undergone photodynamic therapy with verteporfin.RESULTS:Of 548 patients at the first treatment, 14 patients (2.6%) experienced pain during the infusion. Eleven patients were being treated for age-related macular degeneration; their mean age was 81 years, which significantly differed from the mean age of the overall age-related macular degeneration group (P = .003). The pain was mild in eight patients, moderate in four patients, and severe in two patients, with dyspnea and precordial pain. Five of the 14 patients had further courses of photodynamic therapy. After being treated prophylactically 60 minutes before photodynamic therapy, only one patient reported further mild pain.CONCLUSIONS:The biologic mechanisms of back pain may involve a high level of circulating thromboxanes that are induced by the liposomal composition of verteporfin. Prevention may include hydration, nonsteroidal anti-inflammatory drugs, and halving the infusion rate.
Lingua originaleEnglish
pagine (da-a)593-594
Numero di pagine2
RivistaAmerican Journal of Ophthalmology
Volume141
Stato di pubblicazionePublished - 2006

Fingerprint

Photochemotherapy
Back Pain
Pain
Macular Degeneration
verteporfin
Thromboxanes
Dyspnea
Anti-Inflammatory Agents
Incidence

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cita questo

Back pain after photodynamic therapy with verteporfin. / Vadala', Maria; Pece, Alfredo; Manzi, Renato; Calori, Giliola.

In: American Journal of Ophthalmology, Vol. 141, 2006, pag. 593-594.

Risultato della ricerca: Article

Vadala', M, Pece, A, Manzi, R & Calori, G 2006, 'Back pain after photodynamic therapy with verteporfin.', American Journal of Ophthalmology, vol. 141, pagg. 593-594.
Vadala', Maria ; Pece, Alfredo ; Manzi, Renato ; Calori, Giliola. / Back pain after photodynamic therapy with verteporfin. In: American Journal of Ophthalmology. 2006 ; Vol. 141. pagg. 593-594.
@article{bc7e939118da4b11a2eadecf1698918f,
title = "Back pain after photodynamic therapy with verteporfin.",
abstract = "PURPOSE:To report the incidence of back pain after photodynamic therapy, which suggests methods for prevention that are related to its pathogenesis.DESIGN:Retrospective case series.METHODS:We retrospectively observed 548 patients who had undergone photodynamic therapy with verteporfin.RESULTS:Of 548 patients at the first treatment, 14 patients (2.6{\%}) experienced pain during the infusion. Eleven patients were being treated for age-related macular degeneration; their mean age was 81 years, which significantly differed from the mean age of the overall age-related macular degeneration group (P = .003). The pain was mild in eight patients, moderate in four patients, and severe in two patients, with dyspnea and precordial pain. Five of the 14 patients had further courses of photodynamic therapy. After being treated prophylactically 60 minutes before photodynamic therapy, only one patient reported further mild pain.CONCLUSIONS:The biologic mechanisms of back pain may involve a high level of circulating thromboxanes that are induced by the liposomal composition of verteporfin. Prevention may include hydration, nonsteroidal anti-inflammatory drugs, and halving the infusion rate.",
author = "Maria Vadala' and Alfredo Pece and Renato Manzi and Giliola Calori",
year = "2006",
language = "English",
volume = "141",
pages = "593--594",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Back pain after photodynamic therapy with verteporfin.

AU - Vadala', Maria

AU - Pece, Alfredo

AU - Manzi, Renato

AU - Calori, Giliola

PY - 2006

Y1 - 2006

N2 - PURPOSE:To report the incidence of back pain after photodynamic therapy, which suggests methods for prevention that are related to its pathogenesis.DESIGN:Retrospective case series.METHODS:We retrospectively observed 548 patients who had undergone photodynamic therapy with verteporfin.RESULTS:Of 548 patients at the first treatment, 14 patients (2.6%) experienced pain during the infusion. Eleven patients were being treated for age-related macular degeneration; their mean age was 81 years, which significantly differed from the mean age of the overall age-related macular degeneration group (P = .003). The pain was mild in eight patients, moderate in four patients, and severe in two patients, with dyspnea and precordial pain. Five of the 14 patients had further courses of photodynamic therapy. After being treated prophylactically 60 minutes before photodynamic therapy, only one patient reported further mild pain.CONCLUSIONS:The biologic mechanisms of back pain may involve a high level of circulating thromboxanes that are induced by the liposomal composition of verteporfin. Prevention may include hydration, nonsteroidal anti-inflammatory drugs, and halving the infusion rate.

AB - PURPOSE:To report the incidence of back pain after photodynamic therapy, which suggests methods for prevention that are related to its pathogenesis.DESIGN:Retrospective case series.METHODS:We retrospectively observed 548 patients who had undergone photodynamic therapy with verteporfin.RESULTS:Of 548 patients at the first treatment, 14 patients (2.6%) experienced pain during the infusion. Eleven patients were being treated for age-related macular degeneration; their mean age was 81 years, which significantly differed from the mean age of the overall age-related macular degeneration group (P = .003). The pain was mild in eight patients, moderate in four patients, and severe in two patients, with dyspnea and precordial pain. Five of the 14 patients had further courses of photodynamic therapy. After being treated prophylactically 60 minutes before photodynamic therapy, only one patient reported further mild pain.CONCLUSIONS:The biologic mechanisms of back pain may involve a high level of circulating thromboxanes that are induced by the liposomal composition of verteporfin. Prevention may include hydration, nonsteroidal anti-inflammatory drugs, and halving the infusion rate.

UR - http://hdl.handle.net/10447/18386

M3 - Article

VL - 141

SP - 593

EP - 594

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

ER -